Géraldine Durand joined bioMérieux in 2007, her current position is Europe R&D Microbiology Director in charge of all microbiology products developments for Antimicrobial Susceptibility Testing (ETEST®, VITEK®2 AES expert system, RAPIDEC® CARBA etc…), identification (mass spectrometry) and culture (conventional media and chromogenic media).
She received her Pharm D from the University of Lyon, France. After an internship in medical biology and obtaining an MSc in French National Reference Center for Staphylococci, she completed her residency in clinical biology at the Hospices Civils de Lyon where she earned her PhD. She conducted her research work at the French National Reference Center of Staphylococci. Her research was focused on Methicillin-resistant Staphylococcus aureus (MRSA). She described a new emerging MRSA clone.
As the leader of the bioMérieux Europe R&D Microbiology group in recent years her research was directed on rapid microbiology, on mass spectrometry, and also on laboratory automation, mainly driven on the medical value brought by imaging technologies for bacterial culture. Her latest research covers S. aureus characterization through whole genome sequencing (EpiSeqTM).